United States · FDA National Drug Code directory
rizatriptan benzoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-465_c7909d7b-34a6-42b0-ad12-eb25f3ce886e
- Product NDC
- 68462-465
- Form
- TABLET
- Composition / generic term
- rizatriptan benzoate
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20121231
- Source listing expiry
- 20261231
Source-listed ingredients
- RIZATRIPTAN BENZOATE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 12 POUCH in 1 CARTON (68462-465-72) / 1 BLISTER PACK in 1 POUCH / 1 TABLET in 1 BLISTER PACK · 68462-465-72
- 18 POUCH in 1 CARTON (68462-465-99) / 1 BLISTER PACK in 1 POUCH / 1 TABLET in 1 BLISTER PACK · 68462-465-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →